drugset / Trial / NCT02821390
Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections
RandomizedCrossoverTriple-blindSupportive care
Summary
The analgesic effect of Nepafenac 0.1% Ophthalmic Drops on ocular pain related to intravitreal injections will be evaluated. Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nepafenac | Other / unclassified | 0.1 % | Topical |
Indications
No indication recorded.